Market Cap 2.19B
Revenue (ttm) 57.88M
Net Income (ttm) -519.02M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -896.72%
Debt to Equity Ratio 0.00
Volume 5,784,000
Avg Vol 5,411,610
Day's Range N/A - N/A
Shares Out 107.35M
Stochastic %K 82%
Beta 2.37
Analysts Strong Sell
Price Target $33.48

Company Profile

Intellia Therapeutics, Inc., a clinical-stage gene editing company, focuses on the development of curative genome editing treatments. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 that is in Phase 1/2 study for the treatment of hereditary angioedema. It also focusses on the research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune dis...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 285 6200
Address:
40 Erie Street, Suite 130, Cambridge, United States
RocroBio
RocroBio Oct. 4 at 10:12 PM
0 · Reply
Srwitt
Srwitt Oct. 4 at 8:29 PM
$NTLA insiders sold at 10, sold at 13 sold at 20....I am not selling one share 7 to 38..let's go cathy...rfk wants usa to cure ..
0 · Reply
3DBuilds
3DBuilds Oct. 4 at 10:29 AM
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 8:28 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $NTLA Current Share Price: $19.96 Contracts: $NTLA January 15, 2027 $20 Calls Scale in: $7.45- $9.10 Scale out: $11.58-$14.90 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Oct. 3 at 11:48 PM
$NTLA $ASTS $CRML $OKLO $BBIO Give me a better 4 month return 🔥🔥🔥🚀🚀🚀 Next 4 months watch the following make a similar move. Skye Mvis Alt Bbai Alms Beam
1 · Reply
gauravknayak
gauravknayak Oct. 3 at 7:31 PM
$NTLA This will run up next week; the short covering alone will take it to $25+. We just need to make sure market hold up. Still long term I believe this is $LLY or $REGN type big pharma in making which will make money not just licensing the technology but opening new technology to cure some really hard to cure disease. The promise is huge and once the world notices it, I cannot imagine this company will be not acquired for something north of $10 billion in next 2-3 years.
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 4:43 PM
Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve! $KRRO $NBIS $NTLA $HOOD
0 · Reply
highnihilism
highnihilism Oct. 3 at 4:16 PM
$ARES Ares Management Trades: 224 | Total $: 1.15 M | 0.91 × 90-Day Avg $: 1.26 M | Call $: 928.4 K | Put $: 222.4 K | Single-Leg: 97% | Multi-Leg: 3% $CLF Cleveland-Cliffs Trades: 1,691 | Total $: 1.34 M | 0.42 × 90-Day Avg $: 3.21 M | Call $: 927.3 K | Put $: 413.9 K | Single-Leg: 83% | Multi-Leg: 16% $NTLA Intellia Therapeutics Trades: 563 | Total $: 1.01 M | 1.24 × 90-Day Avg $: 811 K | Call $: 922.5 K | Put $: 84 K | Single-Leg: 88% | Multi-Leg: 12% $EXPE Expedia Group Trades: 962 | Total $: 2.01 M | 0.71 × 90-Day Avg $: 2.83 M | Call $: 920.3 K | Put $: 1.09 M | Single-Leg: 86% | Multi-Leg: 14%
0 · Reply
kfcthatsfried
kfcthatsfried Oct. 3 at 4:01 PM
$NTLA lemme get a pull backkkk
0 · Reply
jeojackson
jeojackson Oct. 3 at 3:58 PM
$NTLA Took my profits
0 · Reply
Latest News on NTLA
Why big players are pouring millions in THIS biotech stock

Sep 1, 2025, 8:43 AM EDT - 4 weeks ago

Why big players are pouring millions in THIS biotech stock


RocroBio
RocroBio Oct. 4 at 10:12 PM
0 · Reply
Srwitt
Srwitt Oct. 4 at 8:29 PM
$NTLA insiders sold at 10, sold at 13 sold at 20....I am not selling one share 7 to 38..let's go cathy...rfk wants usa to cure ..
0 · Reply
3DBuilds
3DBuilds Oct. 4 at 10:29 AM
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 8:28 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $NTLA Current Share Price: $19.96 Contracts: $NTLA January 15, 2027 $20 Calls Scale in: $7.45- $9.10 Scale out: $11.58-$14.90 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Oct. 3 at 11:48 PM
$NTLA $ASTS $CRML $OKLO $BBIO Give me a better 4 month return 🔥🔥🔥🚀🚀🚀 Next 4 months watch the following make a similar move. Skye Mvis Alt Bbai Alms Beam
1 · Reply
gauravknayak
gauravknayak Oct. 3 at 7:31 PM
$NTLA This will run up next week; the short covering alone will take it to $25+. We just need to make sure market hold up. Still long term I believe this is $LLY or $REGN type big pharma in making which will make money not just licensing the technology but opening new technology to cure some really hard to cure disease. The promise is huge and once the world notices it, I cannot imagine this company will be not acquired for something north of $10 billion in next 2-3 years.
0 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 4:43 PM
Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve! $KRRO $NBIS $NTLA $HOOD
0 · Reply
highnihilism
highnihilism Oct. 3 at 4:16 PM
$ARES Ares Management Trades: 224 | Total $: 1.15 M | 0.91 × 90-Day Avg $: 1.26 M | Call $: 928.4 K | Put $: 222.4 K | Single-Leg: 97% | Multi-Leg: 3% $CLF Cleveland-Cliffs Trades: 1,691 | Total $: 1.34 M | 0.42 × 90-Day Avg $: 3.21 M | Call $: 927.3 K | Put $: 413.9 K | Single-Leg: 83% | Multi-Leg: 16% $NTLA Intellia Therapeutics Trades: 563 | Total $: 1.01 M | 1.24 × 90-Day Avg $: 811 K | Call $: 922.5 K | Put $: 84 K | Single-Leg: 88% | Multi-Leg: 12% $EXPE Expedia Group Trades: 962 | Total $: 2.01 M | 0.71 × 90-Day Avg $: 2.83 M | Call $: 920.3 K | Put $: 1.09 M | Single-Leg: 86% | Multi-Leg: 14%
0 · Reply
kfcthatsfried
kfcthatsfried Oct. 3 at 4:01 PM
$NTLA lemme get a pull backkkk
0 · Reply
jeojackson
jeojackson Oct. 3 at 3:58 PM
$NTLA Took my profits
0 · Reply
Mummyexe
Mummyexe Oct. 3 at 3:12 PM
$NTLA They're really beating down every pop huh
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 3:11 PM
$NTLA: Unusual Options Activity Alerted CALL flow observed 75x contracts at Strike price of $10 Exp on 01/15/2027 with Premium of $83K and showing BEARISH Sentiment
0 · Reply
elricadon
elricadon Oct. 3 at 1:54 PM
Sold 1/3 $NTLA 20.10 took 101% gain here. Mentioned on x
0 · Reply
ShortsHater
ShortsHater Oct. 3 at 1:10 PM
$BCRX shorts will experience the same pain as $NTLA shorts, shorts are the main reason $NTLA trippled from their low 7’s in the last 6+ months, will happen the same for $BCRX
2 · Reply
Deejay47
Deejay47 Oct. 3 at 11:34 AM
$NTLA https://rarediseaseadvisor.libsyn.com/an-interview-with-catherine-miller-pharmd-of-intellia-therapeutics-on-an-experimental-gene-editing-therapy-for-hae Recommend this for quick take on HAE and why Intellia’s approach is needed.
0 · Reply
gauravknayak
gauravknayak Oct. 3 at 11:06 AM
$NTLA this can go to $25 in near term. After the first BLA next year could be trading near $50+ if data in study is as good as phase 1/2
1 · Reply
Cornelnnj
Cornelnnj Oct. 3 at 6:07 AM
$NTLA 20.99 ovt! This is an absolute rocket ship
1 · Reply
Deejay47
Deejay47 Oct. 3 at 4:32 AM
$NTLA $CRSP $ARKG Short term pipeline keeps providing incredible catalysts for next years. This is way under-appreciated in my opinion. What will be the market cap next year when first bla has been submitted?
0 · Reply
TXBeanCounter
TXBeanCounter Oct. 3 at 2:01 AM
$NTLA $PGNY Know what you hold. Diamond hands. 💎 🤚🏼 🔥 💯 +
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 2 at 11:01 PM
retail running ASTC now! the ASTC Float only 400k could squeeze hard wow $ANGX $PDYN $BTQ $NTLA :
0 · Reply
PSDL75
PSDL75 Oct. 2 at 9:10 PM
$NTLA Who bought the 52 low to ride to the 52 high?
0 · Reply
rxptgh
rxptgh Oct. 2 at 8:13 PM
$NTLA 💥
0 · Reply